10.01.2012 09:20 Uhr, Quelle: Wallstreet online

Merck Serono Initiates Validation Study of the First Quality-of-Life Questionnaire Specific to Phenylketonuria

GENEVA, Switzerland, January 10, 2012 /PRNewswire/ Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced inclusion of the first patient in the validation study for the first quality-of-life questionnaire specific to …

Weiterlesen bei Wallstreet online